These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 31731173)

  • 21. Use and Outcomes of Peripheral Vasopressors in Early Sepsis-Induced Hypotension Across Michigan Hospitals: A Retrospective Cohort Study.
    Munroe ES; Heath ME; Eteer M; Gershengorn HB; Horowitz JK; Jones J; Kaatz S; Tamae Kakazu M; McLaughlin E; Flanders SA; Prescott HC
    Chest; 2024 Apr; 165(4):847-857. PubMed ID: 37898185
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.
    Permpikul C; Tongyoo S; Viarasilpa T; Trainarongsakul T; Chakorn T; Udompanturak S
    Am J Respir Crit Care Med; 2019 May; 199(9):1097-1105. PubMed ID: 30704260
    [No Abstract]   [Full Text] [Related]  

  • 23. Early versus delayed administration of norepinephrine in patients with septic shock.
    Bai X; Yu W; Ji W; Lin Z; Tan S; Duan K; Dong Y; Xu L; Li N
    Crit Care; 2014 Oct; 18(5):532. PubMed ID: 25277635
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ragoonanan D; Nickelsen P; Tran N; Allen B; Emborski R; Legare A; Villela A; Hampson L; Busey K; Shomo E; Broomfield A; Hailu K
    J Intensive Care Med; 2024 Apr; 39(4):306-312. PubMed ID: 37715634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
    Chawla LS; Ostermann M; Forni L; Tidmarsh GF
    Crit Care; 2019 Apr; 23(1):124. PubMed ID: 30992045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Vasopressin as First-Line Treatment of Distributive and Hemorrhagic Shock States.
    Haan BJ; Cadiz ML; Natavio AM
    Ann Pharmacother; 2020 Mar; 54(3):213-218. PubMed ID: 31625395
    [No Abstract]   [Full Text] [Related]  

  • 27. Liberal vs. conservative vasopressor use to maintain mean arterial blood pressure during resuscitation of septic shock: an observational study.
    Subramanian S; Yilmaz M; Rehman A; Hubmayr RD; Afessa B; Gajic O
    Intensive Care Med; 2008 Jan; 34(1):157-62. PubMed ID: 17924093
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
    Oba Y; Lone NA
    J Crit Care; 2014 Oct; 29(5):706-10. PubMed ID: 24857641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The incidence of cardiovascular instability in patients receiving various vasopressor strategies for peri-intubation hypotension.
    Schmitt CJ; Mattson AE; Brown CS; Mara KC; Cabrera D; Sandefur BJ; Wieruszewski ED
    Am J Emerg Med; 2023 Mar; 65():104-108. PubMed ID: 36603354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Push-Dose Vasopressin for Hypotension in Septic Shock.
    Nowadly CD; Catlin JR; Fontenette RW
    J Emerg Med; 2020 Feb; 58(2):313-316. PubMed ID: 32173168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypotension Risk Based on Vasoactive Agent Discontinuation Order in Patients in the Recovery Phase of Septic Shock.
    Sacha GL; Lam SW; Duggal A; Torbic H; Reddy AJ; Bauer SR
    Pharmacotherapy; 2018 Mar; 38(3):319-326. PubMed ID: 29328496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evolving Management Practices for Early Sepsis-induced Hypoperfusion: A Narrative Review.
    Munroe ES; Hyzy RC; Semler MW; Shankar-Hari M; Young PJ; Zampieri FG; Prescott HC
    Am J Respir Crit Care Med; 2023 May; 207(10):1283-1299. PubMed ID: 36812500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Controversies regarding choice of vasopressor therapy for management of septic shock in animals.
    Silverstein DC; Beer KA
    J Vet Emerg Crit Care (San Antonio); 2015; 25(1):48-54. PubMed ID: 25655726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of norepinephrine in septic patients: NOT too little too late.
    Rachoin JS; Dellinger RP
    Crit Care; 2014 Dec; 18(6):691. PubMed ID: 25672524
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should Vasopressors Be Started Early in Septic Shock?
    Cioccari L; Jakob SM; Takala J
    Semin Respir Crit Care Med; 2021 Oct; 42(5):683-688. PubMed ID: 34544185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.
    Hodge EK; Hughes DW; Attridge RL
    Ann Pharmacother; 2016 Oct; 50(10):816-23. PubMed ID: 27340145
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does body weight impact the efficacy of vasopressin therapy in the management of septic shock?
    Miller JT; Welage LS; Kraft MD; Alaniz C
    J Crit Care; 2012 Jun; 27(3):289-93. PubMed ID: 21855282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Continuation of Statin Therapy and Vasopressor Use in Septic Shock.
    Zechmeister C; Hurren J; McNorton K
    Ann Pharmacother; 2015 Jul; 49(7):790-5. PubMed ID: 25896127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intensity of Vasopressor Therapy for Septic Shock and the Risk of In-Hospital Death.
    Brand DA; Patrick PA; Berger JT; Ibrahim M; Matela A; Upadhyay S; Spiegler P
    J Pain Symptom Manage; 2017 May; 53(5):938-943. PubMed ID: 28062334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of very early start of norepinephrine in patients with septic shock: a propensity score-based analysis.
    Ospina-Tascón GA; Hernandez G; Alvarez I; Calderón-Tapia LE; Manzano-Nunez R; Sánchez-Ortiz AI; Quiñones E; Ruiz-Yucuma JE; Aldana JL; Teboul JL; Cavalcanti AB; De Backer D; Bakker J
    Crit Care; 2020 Feb; 24(1):52. PubMed ID: 32059682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.